BioMarin Pharmaceutical, Inc. (BMRN)
63.42
+1.59
(+2.57%)
USD |
NASDAQ |
Feb 19, 16:00
63.42
0.00 (0.00%)
Pre-Market: 08:01
BioMarin Pharmaceutical Market Cap : 12.18B for Feb. 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.502B |
| Gilead Sciences, Inc. | 187.49B |
| Merck & Co., Inc. | 302.46B |
| AbbVie, Inc. | 396.51B |
| Biogen, Inc. | 28.19B |
Market Cap Related Metrics
| PE Ratio | 23.76 |
| PS Ratio | 4.020 |
| PEG Ratio | 0.3914 |
| Price to Book Value | 2.012 |
| Price to Free Cash Flow | 15.02 |
| Price | 63.42 |
| Earnings Yield | 4.21% |
| PEGY Ratio | 0.3914 |
| Operating PE Ratio | 14.50 |
| Normalized PE Ratio | 17.77 |